Tag Archives: regulatory affairs

US Mid-Term Elections: What It Means for Pharma

Daily News Nugget US Mid-Term Elections:  What it Means for Pharma Drink up, even if it’s  only old wine in new bottles… Yesterday’s mid-term congressional poll barely changes the stakes for pharma in its pursuit of its US legislative and regulatory agenda.    The key message coming out of the results is stalemate on the […]
Posted in Op-Ed, Regulatory | Also tagged , , , , , , | 3 Comments

And What Exactly is a Stakeholder?

Pharma’s uncritical use of the word ‘stakeholder’ has increased to the point where it can refer to almost anyone connected to the industry. But this can have serious consequences, warns Reflector. Like it or not (and frankly, I don’t), stakeholders are here to stay in European pharmaceutical affairs. Don’t get me wrong. I’ve no objection […]
Posted in Europe, Global, Guest Blog, Regulatory | Also tagged , , , , , , , | 1 Comment

EU Pharma Policy 2010: Resolutions? Yes. Solutions? Maybe.

Guest blog post by Reflector, Pharm Exec Europe’s Brussels correspondent. There was a new air of hope and confidence among officials and diplomats at the turn of the year in Brussels — or at least there would have been if anyone had been at work. 2010 promises a new beginning with the entry into force […]
Posted in Europe, Global, Regulatory | Also tagged , , , , | Leave a comment
  • Categories

  • Meta